Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy
- 1 January 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (3) , B185-B195
- https://doi.org/10.1016/0002-9149(85)90630-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.Circulation, 1983
- Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.Circulation, 1982
- Diltiazem-induced decrease of exercise-elevated pulmonary arterial diastolic pressure in hypertrophic cardiomyopathy patientsAmerican Heart Journal, 1981
- Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.Circulation, 1978
- Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. B.American Heart Journal, 1975
- Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic BlockadeCirculation, 1967
- The Mechanism of the Intraventricular Pressure Gradient in Idiopathic Hypertrophic Subaortic StenosisCirculation, 1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958